Evidence map›Paper›PMID 41405174›Full record

ArticleClinical and translational science2025

Impact of Administration Time Errors on Clearance Estimation in Pharmacokinetic Analyses.

Katsukuni Fujimoto, Kazuhiko Asari, Kiyoshi Mihara

Abstract read
In one paragraph

Article in Clinical and translational science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Katsukuni FujimotoMusashino University, Tokyo, Japan.ORCID 0009-0009-7963-966X
Kazuhiko AsariMSD K.K., Tokyo, Japan.ORCID 0000-0002-4004-5014
Kiyoshi MiharaMusashino University, Tokyo, Japan.ORCID 0009-0004-4092-4344

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to comprehensively assess the impact of administration time errors on the estimation of clearance (CL), a key pharmacokinetic (PK) parameter used to predict appropriate maintenance dosing and drug exposure. To identify general principles, we simulated 23 cases of hypothetical compounds with varying CL, volume of distribution (Vd), and elimination half-lives (t

Indexed as

Models, BiologicalPharmacokineticsAdministration, OralComputer SimulationDrug Administration ScheduleHalf-LifeHumansMetabolic Clearance RateTime FactorsadherencecomplianceNONMEMpharmacokineticssimulation

Identifiers

PMID41405174
PMCPMC12710077

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.